Zomedica Corp (AMEX: ZOM) launches 2 new canine assays for its TRUFORMA platform. NT-proBNP test detects heart failure, ...
Heart failure has historically been irreversible, but the outcome of a new study suggests that could someday change. At the University of Utah, scientists used a new gene therapy that was shown to ...
New gene therapy reverses heart failure in large animal model Date: December 10, 2024 Source: University of Utah Health Summary: In a single IV injection, a gene therapy targeting cBIN1 can ...
helping identify conditions such as congestive heart failure. It distinguishes between cardiac and respiratory issues, identifies high-risk dogs, and supports monitoring of myxomatous mitral valve ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results